EUVIMEDEUVIMED entdecken
Crossref

Entropy-driven amplification combined with CRISPR-Cas12a to develop a dual-mode biosensor for breast cancer miR-155 detection

Yihua Wang, Min Lan, Min Zhong, Hui Jiang, Qi Wang, Jinbo Liu, Baolin Li

Microchimica Acta · 2026-11 · 193 (11)

DOI: 10.1007/s00604-026-08451-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, online erschienen am 08.10.2026. Verfasst von Yihua Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, the Affiliated Hospital, Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: MicroRNAs, Biosensing Techniques, Breast Neoplasms, CRISPR-Cas Systems. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Scientific research and development center of colleges and universities of the Ministry of Education, The Project of Medical Association of Sichuan Province, Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBiosensing TechniquesBreast NeoplasmsCRISPR-Cas SystemsNucleic Acid Amplification TechniquesHumansFemaleEntropyColorimetryLimit of DetectionBiomarkers, Tumor

Stichwörter der Autor:innen

Breast cancer miRNACRISPR-Cas12aColorimetric visual screeningDual-mode biosensorEntropy driven amplificationFluorescence detection

Substanzen

MicroRNAsMIRN155 microRNA, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Laboratory Medicine, the Affiliated Hospital, Southwest Medical University, Luzhou, China.
  • Molecular Diagnosis of Clinical Diseases Key Laboratory of Luzhou, Luzhou , China.
  • Sichuan Province Engineering Technology Research Center of Molecular Diagnosis of Clinical Diseases, Luzhou, China.
  • Department of Clinical Laboratory, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
  • Department of Laboratory Medicine, the Affiliated Hospital, Southwest Medical University, Luzhou, China. liujb7203@swmu.edu.cn.
  • Molecular Diagnosis of Clinical Diseases Key Laboratory of Luzhou, Luzhou , China. liujb7203@swmu.edu.cn.

Förderung

  • Scientific research and development center of colleges and universities of the Ministry of Education
  • The Project of Medical Association of Sichuan Province
  • Science and Technology Department of Sichuan Province
  • Health Commission of Sichuan Province

Zitieren

APA

Wang, Y., Lan, M., Zhong, M., Jiang, H., Wang, Q., Liu, J., & Li, B. (2026). Entropy-driven amplification combined with CRISPR-Cas12a to develop a dual-mode biosensor for breast cancer miR-155 detection. Microchimica Acta, 193(11). https://doi.org/10.1007/s00604-026-08451-3

Vancouver

Wang Y, Lan M, Zhong M, Jiang H, Wang Q, Liu J, et al. Entropy-driven amplification combined with CRISPR-Cas12a to develop a dual-mode biosensor for breast cancer miR-155 detection. Microchimica Acta. 2026;193(11). doi:10.1007/s00604-026-08451-3

BibTeX
@article{Wang2026,
  author = {Wang, Yihua and Lan, Min and Zhong, Min and Jiang, Hui and Wang, Qi and Liu, Jinbo and Li, Baolin},
  title = {Entropy-driven amplification combined with CRISPR-Cas12a to develop a dual-mode biosensor for breast cancer miR-155 detection},
  journal = {Microchimica Acta},
  year = {2026},
  volume = {193},
  number = {11},
  doi = {10.1007/s00604-026-08451-3}
}
Kostenlos starten →